|
Market Closed -
Oslo Bors
15:45:00 14/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 284.00 NOK | -0.35% |
|
+5.97% | +9.65% |
| 09-20 | Medistim ASA(OB:MEDI) added to S&P Global BMI Index | CI |
| 09-15 | Odin Small Cap rose 4.15% in August, 16 holdings beat expectations | FW |
| Market Cap | 5.2B 544M 489M 457M 414M 777M 51.78B 782M 5.48B 2.14B 26.87B 2.04B 2B 86.44B | P/E 2026 * |
28.6x | P/E 2027 * | 26.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.06B 530M 476M 444M 403M 756M 50.41B 761M 5.33B 2.08B 26.16B 1.99B 1.95B 84.14B | EV / Sales 2026 * |
6.36x | EV / Sales 2027 * | 5.81x |
| Free-Float |
79.47% | Yield 2026 * |
3.04% | Yield 2027 * | 3.15% |
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| MEDI | Real-time | |
CBOE
| MEDIo | Real-time | |
|
Nasdaq Stockholm
| MEDIO | Delayed | |
|
Nasdaq Stockholm
| MEDIO | End-of-day quote | |
|
Deutsche Boerse AG
| MD1 | Delayed | |
|
CBOE
| 0OCD | Real-time | |
|
Börse Stuttgart
| MD1 | Delayed | |
|
Boerse Muenchen
| MD1 | Real-time |
Last Transcript: Medistim ASA
| 1 day | -0.35% | ||
| 1 week | +5.97% | ||
| Current month | +12.25% | ||
| 1 month | +15.45% | ||
| 3 months | +24.56% | ||
| 6 months | +21.37% | ||
| Current year | +9.65% |
| 1 week | 269 |  | 289 |
| 1 month | 240 | | 289 |
| Current year | 186.5 | | 289 |
| 1 year | 186.5 | | 292 |
| 3 years | 130 | | 292 |
| 5 years | 130 | | 402.5 |
| 10 years | 60 | | 409 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 31/08/2009 | |
| Director of Finance/CFO | - | 31/12/2000 | |
Jonas Tysso
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 31/12/1999 | |
Tove Raanes
BRD | Director/Board Member | 49 | 31/12/2013 |
| Director/Board Member | 56 | 31/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/03/25 | Buy | Chairman | 860,735 | 4.6939% | ||
| 27/01/25 | Buy | Chairman | 45,000 | 0.2454% | ||
| 09/01/25 | Buy | Chairman | 30,000 | 0.1636% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.35% | +5.97% | +22.94% | +45.27% | 548M | |
| +1.53% | +1.68% | +28.03% | +39.42% | 245B | |
| +0.83% | +2.84% | +8.99% | +7.29% | 157B | |
| -0.43% | +1.38% | -3.70% | +53.85% | 149B | |
| -0.72% | +3.42% | -55.32% | -13.17% | 62.77B | |
| +0.38% | +3.92% | -13.68% | -15.68% | 49.74B | |
| +1.38% | +0.78% | +17.84% | +22.14% | 49.15B | |
| -1.42% | +5.26% | +3.37% | +37.59% | 48.84B | |
| +1.40% | +2.90% | +26.05% | +57.45% | 48.38B | |
| +1.73% | +0.14% | +31.06% | +72.84% | 42.17B | |
| Average | +0.43% | +2.86% | +6.56% | +30.70% | 85.25B | |
| Weighted average by Cap. | +0.65% | +2.53% | +8.44% | +30.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 795M 83.27M 74.86M 69.86M 63.32M 119M 7.92B 120M 838M 327M 4.11B 313M 306M 13.23B | 868M 90.86M 81.69M 76.24M 69.09M 130M 8.65B 131M 915M 357M 4.49B 341M 334M 14.43B |
| Net income | 182M 19.01M 17.09M 15.95M 14.46M 27.14M 1.81B 27.31M 191M 74.74M 939M 71.37M 69.83M 3.02B | 202M 21.16M 19.02M 17.75M 16.09M 30.21M 2.01B 30.39M 213M 83.19M 1.04B 79.43M 77.71M 3.36B |
| Net Debt | -138M -14.45M -13M -12.13M -10.99M -20.64M -1.38B -20.76M -146M -56.83M -714M -54.27M -53.09M -2.3B | -158M -16.5M -14.83M -13.84M -12.54M -23.55M -1.57B -23.7M -166M -64.86M -815M -61.93M -60.59M -2.62B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/10/26 | NOK 284.00 | -0.35% | 11,123 |
| 13/10/26 | NOK 285.00 | +0.71% | 10,860 |
| 12/10/26 | NOK 283.00 | +0.71% | 15,474 |
| 09/10/26 | NOK 281.00 | +3.69% | 24,968 |
| 08/10/26 | NOK 271.00 | +1.12% | 8,159 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDI Stock
Select your edition
All financial news and data tailored to specific country editions
